Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases.
Saved in:
| Title: | Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases. |
|---|---|
| Authors: | Scalia IG; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA., Sonbol MB; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Farina JM; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA., Pereyra M; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA., Wang Y; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA., Bekaii-Saab TS; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Yang M; Department of Radiology, Mayo Clinic, Phoenix, Arizona, USA., Connolly HM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Pellikka PA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Herrmann J; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Halfdanarson TR; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Starr JS; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA., Luis SA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Arsanjani R; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA., Ayoub C; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA. |
| Source: | JACC. CardioOncology [JACC CardioOncol] 2024 Nov 12; Vol. 6 (6), pp. 982-984. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
